Yili Chuanning Biotechnology Co. Ltd. A (301301.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · China · ISIN CNE100005WX0

Price
7.92 CNY
Market cap
17.66 bn CNY
P/E (2025)
22.97
P/S (2025)
3.83
Dividend yield
2.18 %
Net margin
16.66 %
Return on equity (ROE)
9.51 %
Return on assets (ROA)
7.37 %

Yili Chuanning Biotechnology Co. Ltd. A financials

Fiscal year20242025
Revenue5.76 bn CNY4.62 bn CNY
Gross profit2.10 bn CNY1.35 bn CNY
Operating income1.76 bn CNY1.02 bn CNY
EBIT1.72 bn CNY972.51 m CNY
Net income1.40 bn CNY769.01 m CNY
Diluted EPS – continuing operations0.63 CNY0.34 CNY

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Yili Chuanning Biotechnology Co. Ltd. A

Yili Chuanning Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research, development, and industrialization of bio-fermentation technology and synthetic biology products in China and internationally. It offers antibiotic intermediates comprising erythromycin thiofluorate; cephalosporin intermediates consisting of 7-aminocephalosporanic acid (7-ACA), 7-amino-3-deacetoxycephalosporinic acid (7-ADCA), and D-7ACA; penicillin intermediates, such as 6-aminopenicillanic acid (6-APA) and penicillin G potassium salt; ursodeoxycholic acid; coenzyme Q10 mycelia; and other products. It also provides synthetic biology products, including bisabolol, 5-hydroxytryptophan, ergothioneine, ectoine, inositol, squalane, polyhydroxyalkanoate (PHA), and phytosphingosine. In addition, the company engages in trading, crop cultivation, detection, technical consultation, and asset investment activities. The company was incorporated in 2010 and is based in Yining, China. Yili Chuanning Biotechnology Co.,Ltd. operates as a subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.